These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 6966626

  • 1. Antibacterial activity of new beta-lactam antibiotics on cefoxitin-resistant strains of Bacteroides fragilis.
    Dornbusch K, Olsson-Lijequist B, Nord CE.
    J Antimicrob Chemother; 1980 Mar; 6(2):207-16. PubMed ID: 6966626
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Detection of beta-lactamases in the Bacteroides fragilis group].
    Martin C, Dubreuil L, Sedallian A, Romond C.
    Pathol Biol (Paris); 1990 May; 38(5):470-3. PubMed ID: 2367153
    [Abstract] [Full Text] [Related]

  • 4. In-vitro study of the susceptibility of cefoxitin/cefotetan resistant Bacteroides fragilis group strains to various other antimicrobial agents.
    Aldridge KE, Henderberg A, Sanders CV.
    J Antimicrob Chemother; 1990 Sep; 26(3):353-9. PubMed ID: 2228826
    [Abstract] [Full Text] [Related]

  • 5. Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis.
    Mastrantonio P, Spigaglia P, Sebastianelli A.
    Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):475-80. PubMed ID: 7957267
    [Abstract] [Full Text] [Related]

  • 6. New findings in beta-lactam and metronidazole resistant Bacteroides fragilis group.
    Fang H, Edlund C, Hedberg M, Nord CE.
    Int J Antimicrob Agents; 2002 May; 19(5):361-70. PubMed ID: 12007843
    [Abstract] [Full Text] [Related]

  • 7. Characterization of beta-lactamases in clinical isolates of Bacteroides.
    Eley A, Greenwood D.
    J Antimicrob Chemother; 1986 Sep; 18(3):325-33. PubMed ID: 3490466
    [Abstract] [Full Text] [Related]

  • 8. Antibiotic susceptibility of anaerobic bacteria with special reference to Bacteroides fragilis.
    Dornbusch K, Nord CE, Olsson-Liljeqvist B.
    Scand J Infect Dis Suppl; 1979 Sep; (19):17-25. PubMed ID: 37593
    [Abstract] [Full Text] [Related]

  • 9. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
    Jacobs MR, Spangler SK, Appelbaum PC.
    J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
    [Abstract] [Full Text] [Related]

  • 10. Emergence of fluoroquinolone resistance in Bacteroides fragilis accompanied by resistance to beta-lactam antibiotics.
    Kato N, Miyauchi M, Muto Y, Watanabe K, Ueno K.
    Antimicrob Agents Chemother; 1988 Sep; 32(9):1437-8. PubMed ID: 2848446
    [Abstract] [Full Text] [Related]

  • 11. Characterization of three different beta-lactamases from the Bacteroides fragilis group.
    Olsson-Liljequist B, Dornbusch K, Nord CE.
    Antimicrob Agents Chemother; 1980 Aug; 18(2):220-5. PubMed ID: 6969573
    [Abstract] [Full Text] [Related]

  • 12. Enhanced antimicrobial activity of old and new beta-lactams against cefoxitin-resistant Bacteroides fragilis group isolates by beta-lactamase inhibitors.
    Aldridge KE, Henderberg A, Sanders CV.
    J Antimicrob Chemother; 1990 May; 25(5):873-5. PubMed ID: 2373670
    [No Abstract] [Full Text] [Related]

  • 13. Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis.
    Cuchural GJ, Tally FP, Storey JR, Malamy MH.
    Antimicrob Agents Chemother; 1986 May; 29(5):918-20. PubMed ID: 3488018
    [Abstract] [Full Text] [Related]

  • 14. Activity of newer beta-lactam agents against clinical isolates of Bacteroides fragilis and other Bacteroides species.
    O'Keefe JP, Venezio FR, DiVincenzo CA, Shatzer KL.
    Antimicrob Agents Chemother; 1987 Dec; 31(12):2002-4. PubMed ID: 3439807
    [Abstract] [Full Text] [Related]

  • 15. The effect of beta-lactam antibiotics on the growth curves of Bacteroides fragilis, obtained with the MS-2 system.
    Yourassowsky E, Van der Linden MP, Lismont MJ, Labbé M, Crokaert F.
    J Antimicrob Chemother; 1981 Sep; 8(3):219-24. PubMed ID: 6457023
    [No Abstract] [Full Text] [Related]

  • 16. Antimicrobial effect of beta-lactam antibiotic combinations against Bacteroides fragilis in vitro.
    Bansal MB, Thadepalli H.
    Antimicrob Agents Chemother; 1983 Jan; 23(1):166-8. PubMed ID: 6830206
    [Abstract] [Full Text] [Related]

  • 17. A new potent beta-lactamase inhibitor, BRL 42715, with inherent activity against Bacteroides fragilis group strains.
    Aldridge KE.
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S335-8. PubMed ID: 8324143
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the activity of imipenem and beta-lactams combined with sulbactam and clavulanic acid in beta-lactamase-producing strains of Bacteroides fragilis.
    Martín MA, Castillo AM, Liébana J, Marín A, Alados JC, Piédrola G.
    J Hyg Epidemiol Microbiol Immunol; 1991 Jun; 35(2):189-97. PubMed ID: 1940333
    [Abstract] [Full Text] [Related]

  • 19. The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.
    Wise R, Gillett AP, Andrews JM.
    J Antimicrob Chemother; 1979 May; 5(3):301-6. PubMed ID: 113377
    [No Abstract] [Full Text] [Related]

  • 20. R-plasmid mediated transfer of beta-lactam resistance in Bacteroides fragilis.
    Yamaoka K, Watanabe K, Muto Y, Katoh N, Ueno K, Tally FP.
    J Antibiot (Tokyo); 1990 Oct; 43(10):1302-6. PubMed ID: 2258328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.